On 2026-03-05, BridgeBio Oncology Therapeutics, Inc (BBOT) announced earnings per share of $-0.49 for the fiscal quarter ending 2025-12-31, beating the average analyst estimate of $-0.67.

The next expected annoucement date for quarterly earnings is 2026-06-04, with an average estimated earnings per share of $-0.51 for the fiscal quarter ending 2026-03-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.